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Abstract
Non-immune pregnant women are at risk of severe measles. As the measles vaccination is contraindicated during pregnancy, women should
be vaccinated before conception or during the postpartum period. Nevertheless, measles serology is not recommended during pregnancy in
France, and there are no data available concerning measles susceptibility and its associated risk factors among pregnant women. The
socio-demographic determinants of measles seronegativity have been identiﬁed in a prospective cohort of 826 pregnant women in Paris,
France. Measles seronegativity was 10.41% (95% CI 8.32–12.50). Women from higher socio-economic groups, born in France after 1980,
were more frequently seronegative.
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Abstract
The incidence of respiratory syncytial virus (RSV) and inﬂuenza virus infection was determined during three RSV seasons in 158 adult
patients consecutively admitted to the intensive care unit with community-acquired respiratory failure. Nasopharyngeal swabs were tested
for the presence of RSV and inﬂuenza virus by real-time polymerase chain reaction. Six patients (4%) were positive for RSV and all
recovered. This ﬁnding was in sharp contrast to inﬂuenza (23 (15%) patients, 4 (17%) deaths). In conclusion, even in the midst of the RSV
season, RSV is an infrequent cause of respiratory failure in adults admitted to the intensive care unit.
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